These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6217004)

  • 41. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
    Karavodin LM; Golub SH
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimation of polymeric IgA in human serum: an assay based on binding of radiolabeled human secretory component with applications in the study of IgA nephropathy, IgA monoclonal gammopathy, and liver disease.
    Newkirk MM; Klein MH; Katz A; Fisher MM; Underdown BJ
    J Immunol; 1983 Mar; 130(3):1176-81. PubMed ID: 6822732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isotype-specificity of helper T cell clones: Fc alpha receptors regulate T and B cell collaboration for IgA responses.
    Kiyono H; Phillips JO; Colwell DE; Michalek SM; Koopman WJ; McGhee JR
    J Immunol; 1984 Sep; 133(3):1087-9. PubMed ID: 6235278
    [No Abstract]   [Full Text] [Related]  

  • 44. Subpopulations of T alpha cells in patients with IgA nephropathy: correlation between T alpha 4 cells and in vitro IgA production.
    Yasumoto Y; Suga T; Miura M; Endoh M; Nomoto H; Tomino Y; Nomoto Y; Sakai H
    Clin Immunol Immunopathol; 1989 May; 51(2):232-9. PubMed ID: 2784755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating immune complexes, the concentration of serum IgA and the distribution of HLA antigens in IgA nephropathy.
    Mustonen J; Pasternack A; Helin H; Rilva A; Penttinen K; Wager O; Harmoinen A
    Nephron; 1981; 29(3-4):170-5. PubMed ID: 7329493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymphocyte populations in the peripheral blood from patients with IgA nephropathy.
    Fiorini G; Fornasieri A; Sinico R; Colasanti G; Gibelli A; Corneo R; D'Amico G
    Nephron; 1982; 31(4):354-7. PubMed ID: 7177270
    [No Abstract]   [Full Text] [Related]  

  • 47. Increase of IgA-bearing peripheral blood lymphocytes in families of patients with IgA nephropathy.
    Sakai H; Nomoto Y; Arimori S; Komori K; Inouye H; Tsuji K
    Am J Clin Pathol; 1979 Sep; 72(3):452-6. PubMed ID: 573063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated Numbers of Circulating Very Small Embryonic-Like Stem Cells (VSELs) and Intermediate CD14++CD16+ Monocytes in IgA Nephropathy.
    Eljaszewicz A; Kleina K; Grubczak K; Radzikowska U; Zembko P; Kaczmarczyk P; Tynecka M; Dworzanczyk K; Naumnik B; Moniuszko M
    Stem Cell Rev Rep; 2018 Oct; 14(5):686-693. PubMed ID: 30022351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case of rapidly progressive IgA nephropathy in a patient with exacerbation of Crohn's disease.
    Choi JY; Yu CH; Jung HY; Jung MK; Kim YJ; Cho JH; Kim CD; Kim YL; Park SH
    BMC Nephrol; 2012 Aug; 13():84. PubMed ID: 22866754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune response of tonsillar lymphocytes to Haemophilus parainfluenzae in patients with IgA nephropathy.
    Suzuki S; Fujieda S; Sunaga H; Sugimoto H; Yamamoto C; Kimura H; Abo T; Gejyo F
    Clin Exp Immunol; 2000 Feb; 119(2):328-32. PubMed ID: 10632671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T-cell epitopes recognized within the 65,000 MW hsp in patients with IgA nephropathy.
    Warr K; Fortune F; Namie S; Wilson A; Shinnick T; Van der Zee R; Williams G; Lehner T
    Immunology; 1997 Jul; 91(3):399-405. PubMed ID: 9301529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathogenesis of idiopathic IgA nephropathy.
    Williams DG
    Pediatr Nephrol; 1993 Jun; 7(3):303-11. PubMed ID: 8518104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IgA nephropathy in children and adults.
    Yoshikawa N; Nakamura H; Ito H
    Springer Semin Immunopathol; 1994; 16(1):105-20. PubMed ID: 7997941
    [No Abstract]   [Full Text] [Related]  

  • 54. Autologous rosette forming cells in patients with renal diseases.
    Kuramochi T; Ohnuki T; Inoue T; Ishida M
    Clin Exp Immunol; 1983 Dec; 54(3):765-70. PubMed ID: 6606516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis.
    Coppo R; Basolo B; Piccoli G; Mazzucco G; Bulzomì MR; Roccatello D; De Marchi M; Carbonara AO; Barbiano di Belgiojoso G
    Clin Exp Immunol; 1984 Sep; 57(3):583-90. PubMed ID: 6467681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo alteration of antibody production in patients with IgA nephropathy.
    Endoh M; Suga T; Miura M; Tomino Y; Nomoto Y; Sakai H
    Clin Exp Immunol; 1984 Sep; 57(3):564-70. PubMed ID: 6380836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Humoral immune response in patients with IgA and IgM glomerulonephritis.
    Pasternack A; Mustonen J; Leinikki P
    Clin Exp Immunol; 1986 Jan; 63(1):228-33. PubMed ID: 3955883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy.
    van den Wall Bake AW; Daha MR; van der Ark A; Hiemstra PS; Radl J; van Es LA
    Clin Exp Immunol; 1988 Oct; 74(1):115-20. PubMed ID: 3219797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibodies to viruses of the herpes group in glomerulonephritis of membranous, membranoproliferative and IgA types.
    Uj M; Szücs G; Nagy J; Trinn C
    Int Urol Nephrol; 1988; 20(2):201-9. PubMed ID: 2838427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune response to oral polio vaccine in patients with IgA glomerulonephritis.
    Leinikki PO; Mustonen J; Pasternack A
    Clin Exp Immunol; 1987 Apr; 68(1):33-8. PubMed ID: 2820631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.